Covidien Receives FDA Premarket Approval for Pipeline Embolization Device

Covidien COV today announced that it received Premarket Approval from the U.S. Food and Drug Administration for the Pipeline® Embolization Device, indicated for the endovascular treatment of adults (22 years of age or older) with large or giant wide-necked intracranial aneurysms in the internal carotid artery from the petrous to the superior hypophyseal segments.